BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19149104)

  • 1. Evaluation of microvessel density (MVD) in canine mammary tumours by quantitative immunohistochemistry of the claudin-5 molecule.
    Jakab C; Halász J; Kiss A; Schaff Z; Szász AM; Rusvai M; Tóth ZA; Kulka J
    Acta Vet Hung; 2008 Dec; 56(4):495-510. PubMed ID: 19149104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR and microvessel density in canine malignant mammary tumours.
    Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
    Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
    Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
    Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
    Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
    Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
    Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
    Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry.
    Restucci B; De Vico G; Maiolino P
    Vet Pathol; 2000 Jul; 37(4):297-301. PubMed ID: 10896390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.
    Flores AR; Rêma A; Carvalho F; Faustino A; Dias Pereira P
    J Comp Pathol; 2014; 150(2-3):169-74. PubMed ID: 24220012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Grade Mammary Gland Tumors in Dogs Have Greater VEGF-A and BMP2 Immunostaining and Higher CD31 Blood Vessel Density.
    Franco PIR; Pereira JX; Ferreira HH; de Menezes LB; Miguel MP
    Top Companion Anim Med; 2023; 53-54():100778. PubMed ID: 37011834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
    Ek ET; Ojaimi J; Kitagawa Y; Choong PF
    Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the claudin-4 molecule in benign and malignant canine hepatoid gland tumours.
    Jakab C; Rusvai M; Szabó Z; Szabára A; Kulka J
    Acta Vet Hung; 2009 Dec; 57(4):463-75. PubMed ID: 19897451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 in canine mammary tumours.
    Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
    J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.